Sustained-release formulations of topiramate
US9555004B2 · kind B2 · utility
0Cited by
84References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2015 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Apr 10, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.